6930
W. Wei et al. / Bioorg. Med. Chem. Lett. 19 (2009) 6926–6930
Acknowledgments
3. McGovern, B. H. J. Acquir. Immune Defic. Syndr. 2007, 45, S47.
4. (a) Simmonds, P. J. Gen. Virol. 2004, 85, 3173; (b) Cristina, J.; del Pilar Moreno,
M.; Moratorio, G. Virus Res. 2007, 127, 185.
The Scripps-Florida workers thank Prof. Weissmann (Depart-
ment of Infectology, The Scripps Research Institute-Scripps Florida)
for helpful discussions, Dr. T. Tellinghuisen (Department of Infec-
tology, The Scripps Research Institute-Scripps Florida) for help
with the HCV studies, Pierre Baillargeon and Lina Deluca (Depart-
ment of Lead Identification, The Scripps Research Institute-Scripps
Florida) for help with formatting the CMLD-BU library, Peter Chase
(Department of Lead Identification, The Scripps Research Institute-
Scripps Florida) for his support at the HTS facility, and the Factor
Foundation (ADS) for generous support. This is manuscript
#20,383 of The Scripps Research Institute. The Boston University
group thanks Professors John Porco and Aaron Beeler for helpful
discussions, and NIGMS CMLD initiative (P50 GM067041 and P41
GM086180) for financial support. We (CMLD-BU) are also grateful
to the National Science Foundation for supporting the purchase of
the NMR (CHE 0619339) and HRMS (CHE 0443618) spectrometers
used in this work.
5. (a) Courcambeck, J.; Bouzidi, M.; Perbost, R.; Jouirou, B.; Amrani, N.; Cacoub, P.;
Pepe, G.; Sabatier, J. M.; Halfon, P. Antivir. Ther. 2006, 11, 847; (b) DeFrancesco,
R.; Carfi, A. Adv. Drug Delivery Rev. 2007, 59, 1242.
6. Kota, S.; Scampavia, L.; Spicer, T.; Beeler, A. B.; Takahashi, V.; Coito, C.; Snyder, J.
K.; Porco, J. A., Jr.; Hodder, P.; Strosberg, A. D. Assay Drug Dev. Tech., in press.
7. Kota, S.; Coito, C.; Mousseau, G.; Lavergne, J.-P.; Strosberg, A. D. J. Gen. Virol.
2009, 90, 1319.
8. The N-alkylated tryptophan derivatives were prepared by reaction of the N-
BOC tryptophan methyl ester with the appropriate alkyl halide after treatment
with NaH at À30 to À78 °C in THF. No racemization was observed under these
conditions.
9. Benson, S. C.; Lee, L.; Yang, L.; Snyder, J. K. Tetrahedron 1999, 62, 471.
10. Benson, S. C.; Gross, J. L.; Snyder, J. K. J. Org. Chem. 1990, 55, 3257.
11. Lamarre, D.; Anderson, P. C.; Bailey, M.; Beaulieum, P.; Bolger, G.; Bonneau, P.;
Bös, M.; Cameron, D. R.; Cartier, M.; Cordingley, M. G.; Faucher, A. M.;
Goudreau, N.; Kawai, S. H.; Kukolj, G.; Lagacé, L.; LaPlante, S. R.; Narjes, H.;
Poupart, M.-A.; Rancourt, J.; Sentjens, R. E.; St. George, R.; Simoneau, B.;
Steinmann, G.; Thibeault, D.; Tsantrizos, Y. S.; Weldon, S. M.; Yong, C.-L.;
Llinàs-Brunet, M. Nature 2003, 426, 186.
12. For some reviews on small molecule inhibitors of protein–protein interactions:
(a) Arkin, M. R.; Wells, J. A. Nat. Rev. Drug Disc. 2004, 3, 301; (b) Fry, D. C.
Biopolymers 2006, 84, 535; (c) Dudkina, A. S.; Lindsley, C. W. Curr. Top. Med.
Chem. 2007, 7, 952; (d) Blazer, L. L.; Neubig, R. R. Neuropsychopharm. Rev. 2009,
34, 126.
References and notes
1. Giannini, C.; Brechot, C. Cell Death Differ. 2003, 10, S27.